Coronado Biosciences appoints Harlan F. Weisman, M.D. as CEO

January 2, 2013

Coronado Biosciences announced the appointment of Harlan F. Weisman, M.D., a director for the company since August 2012, as its new chairman and CEO. Dr. Weisman was most recently at Johnson and Johnson, where he held a number of leadership positions, and before that he was the head of R&D at Centocor, the developer of Remicade, which was acquired by JNJ.